Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06312670
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-02-16
Brief Title:
Combining EPI-7386 with Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer
Sponsor:
Pedro Barata MD MSc
Organization:
Case Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Hormone-sensitive Prostate Cancer mHSPC |
| Prostate Cancer |
| Prostate Adenocarcinoma |